Affimed NV (AFMD)

[BobDoleYahoo]

I compared $FATE to $AFMD. $FATE currently trades at double value w/ similar pipeline. $AFMD should be trading double $ digits. This is by far the best read. Even Zack's is wrong on the closing date. They quoted 3rd quarter 2019. It's 2018. I wrote them to let them know they made a typo. So as I and others have already noted, the $96 million + $5 billion is just part of it. Affirmed will also get additional $$ from net sales royalties.

The ABSOLUTE best part is: Genentech is willing to foot most of the R&D expense. That means less dilution & more money reimbursed. Plus since they are projected to last through 2019 with their current cash BEFORE the deal, the CEO expects the $24 million per month (which is close to what they burn per year) to extend that out much further. My guess is possibly another full year, possibly two into 2020-2021, even with ramped up R&D.

http://www.bioworld.com/content/96m-committed-affimed-shares-surge-150-potential-51b-genentech-deal-0